Search Results - "Kankanala, Jayakanth"

Refine Results
  1. 1

    Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H by Kankanala, Jayakanth, Kirby, Karen A, Liu, Feng, Miller, Lena, Nagy, Eva, Wilson, Daniel J, Parniak, Michael A, Sarafianos, Stefan G, Wang, Zhengqiang

    Published in Journal of medicinal chemistry (26-05-2016)
    “…Targeting the clinically unvalidated reverse transcriptase (RT) associated ribonuclease H (RNase H) for human immunodeficiency virus (HIV) drug discovery…”
    Get full text
    Journal Article
  2. 2

    Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules by Vernekar, Sanjeev Kumar V, Sahani, Rajkumar Lalji, Casey, Mary C, Kankanala, Jayakanth, Wang, Lei, Kirby, Karen A, Du, Haijuan, Zhang, Huanchun, Tedbury, Philip R, Xie, Jiashu, Sarafianos, Stefan G, Wang, Zhengqiang

    Published in Viruses (16-04-2020)
    “…HIV-1 capsid protein (CA) plays an important role in many steps of viral replication and represents an appealing antiviral target. Several CA-targeting small…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Discovery of N-benzyl hydroxypyridone carboxamides as a novel and potent antiviral chemotype against human cytomegalovirus (HCMV) by Senaweera, Sameera, Edwards, Tiffany C., Kankanala, Jayakanth, Wang, Yan, Sahani, Rajkumar Lalji, Xie, Jiashu, Geraghty, Robert J., Wang, Zhengqiang

    Published in Acta pharmaceutica Sinica. B (01-04-2022)
    “…Current drugs for treating human cytomegalovirus (HCMV) infections are limited by resistance and treatment-associated toxicities. In developing mechanistically…”
    Get full text
    Journal Article
  5. 5
  6. 6

    In silico design and biological evaluation of a dual specificity kinase inhibitor targeting cell cycle progression and angiogenesis by Latham, Antony M, Kankanala, Jayakanth, Fearnley, Gareth W, Gage, Matthew C, Kearney, Mark T, Homer-Vanniasinkam, Shervanthi, Wheatcroft, Stephen B, Fishwick, Colin W G, Ponnambalam, Sreenivasan

    Published in PloS one (13-11-2014)
    “…Protein kinases play a central role in tumor progression, regulating fundamental processes such as angiogenesis, proliferation and metastasis. Such enzymes are…”
    Get full text
    Journal Article
  7. 7

    Receptor tyrosine kinase structure and function in health and disease by A. Karpov, Oleg, W. Fearnley, Gareth, A. Smith, Gina, Kankanala, Jayakanth, J. McPherson, Michael, C. Tomlinson, Darren, A. Harrison, Michael, Ponnambalam, Sreenivasan

    Published in AIMS biophysics (01-01-2015)
    “…Receptor tyrosine kinases (RTKs) are membrane proteins that control the flow of information through signal transduction pathways, impacting on different…”
    Get full text
    Journal Article
  8. 8

    Isoquinoline-1,3-diones as Selective Inhibitors of Tyrosyl DNA Phosphodiesterase II (TDP2) by Kankanala, Jayakanth, Marchand, Christophe, Abdelmalak, Monica, Aihara, Hideki, Pommier, Yves, Wang, Zhengqiang

    Published in Journal of medicinal chemistry (24-03-2016)
    “…Tyrosyl DNA phosphodiesterase II (TDP2) is a recently discovered enzyme that specifically repairs DNA damages induced by topoisomerase II (Top2) poisons and…”
    Get full text
    Journal Article
  9. 9

    Novel deazaflavin tyrosyl-DNA phosphodiesterase 2 (TDP2) inhibitors by Kiselev, Evgeny, Ravji, Azhar, Kankanala, Jayakanth, Xie, Jiashu, Wang, Zhengqiang, Pommier, Yves

    Published in DNA repair (01-01-2020)
    “…•Novel deazaflavin derivative ZW-1288 is a potent inhibitor of recombinant and cellular human TDP2.•ZW-1288 specifically potentiates cytotoxic action of the…”
    Get full text
    Journal Article
  10. 10

    5′-Silylated 3′-1,2,3-triazolyl Thymidine Analogues as Inhibitors of West Nile Virus and Dengue Virus by Vernekar, Sanjeev Kumar V, Qiu, Li, Zhang, Jing, Kankanala, Jayakanth, Li, Hongmin, Geraghty, Robert J, Wang, Zhengqiang

    Published in Journal of medicinal chemistry (14-05-2015)
    “…West Nile virus (WNV) and Dengue virus (DENV) are important human pathogens for which there are presently no vaccine or specific antivirals. We report herein a…”
    Get full text
    Journal Article
  11. 11

    Inhibition of Human Cytomegalovirus pUL89 Terminase Subunit Blocks Virus Replication and Genome Cleavage by Wang, Yan, Mao, Lili, Kankanala, Jayakanth, Wang, Zhengqiang, Geraghty, Robert J

    Published in Journal of virology (01-02-2017)
    “…The human cytomegalovirus terminase complex cleaves concatemeric genomic DNA into unit lengths during genome packaging and particle assembly. This process is…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Hydroxypyridonecarboxylic Acids as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease by Kankanala, Jayakanth, Wang, Yan, Geraghty, Robert J., Wang, Zhengqiang

    Published in ChemMedChem (20-08-2018)
    “…Human cytomegalovirus (HCMV) infection poses a major health threat to immunocompromised individuals. Until recently, treatment of HCMV infection has relied…”
    Get full text
    Journal Article
  14. 14

    Triazolopyrimidine and triazolopyridine scaffolds as TDP2 inhibitors by Ribeiro, Carlos J.A., Kankanala, Jayakanth, Xie, Jiashu, Williams, Jessica, Aihara, Hideki, Wang, Zhengqiang

    Published in Bioorganic & medicinal chemistry letters (15-01-2019)
    “…[Display omitted] •Four derivatives possess significant TDP2 inhibition (IC50 < 50 µM).•17z (IC50 of 21.0 ± 2.1 µM) shows excellent cell permeability and no…”
    Get full text
    Journal Article
  15. 15

    Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H by Kankanala, Jayakanth, Kirby, Karen A., Huber, Andrew D., Casey, Mary C., Wilson, Daniel J., Sarafianos, Stefan G., Wang, Zhengqiang

    Published in European journal of medicinal chemistry (01-12-2017)
    “…Human immunodeficiency virus (HIV) reverse transcriptase (RT) associated ribonuclease H (RNase H) is the only HIV enzymatic function not targeted by current…”
    Get full text
    Journal Article
  16. 16

    3‑Hydroxypyrimidine-2,4-dione-5‑N‑benzylcarboxamides Potently Inhibit HIV‑1 Integrase and RNase H by Wu, Bulan, Tang, Jing, Wilson, Daniel J, Huber, Andrew D, Casey, Mary C, Ji, Juan, Kankanala, Jayakanth, Xie, Jiashu, Sarafianos, Stefan G, Wang, Zhengqiang

    Published in Journal of medicinal chemistry (14-07-2016)
    “…Resistance selection by human immunodeficiency virus (HIV) toward known drug regimens necessitates the discovery of structurally novel antivirals with a…”
    Get full text
    Journal Article
  17. 17
  18. 18

    5-Aminothiophene-2,4-dicarboxamide analogues as hepatitis B virus capsid assembly effectors by Tang, Jing, Huber, Andrew D., Pineda, Dallas L., Boschert, Kelsey N., Wolf, Jennifer J., Kankanala, Jayakanth, Xie, Jiashu, Sarafianos, Stefan G., Wang, Zhengqiang

    Published in European journal of medicinal chemistry (15-02-2019)
    “…Chronic hepatitis B virus (HBV) infection represents a major health threat. Current FDA-approved drugs do not cure HBV. Targeting HBV core protein (Cp)…”
    Get full text
    Journal Article
  19. 19

    Repurposing N-hydroxy thienopyrimidine-2,4-diones (HtPD) as inhibitors of human cytomegalovirus pUL89 endonuclease: Synthesis and biological characterization by He, Tianyu, Edwards, Tiffany C., Majima, Ryuichi, Jung, Eunkyung, Kankanala, Jayakanth, Xie, Jiashu, Geraghty, Robert J., Wang, Zhengqiang

    Published in Bioorganic chemistry (01-12-2022)
    “…[Display omitted] •Metal-chelating HIV RNase H inhibitors repurposed as HCMV pUL89-C inhibitors.•New isomeric N-hydroxy thienopyrimidine-2,4-dione (HtPD)…”
    Get full text
    Journal Article
  20. 20

    New fluorescence-based high-throughput screening assay for small molecule inhibitors of tyrosyl-DNA phosphodiesterase 2 (TDP2) by Ribeiro, Carlos J.A., Kankanala, Jayakanth, Shi, Ke, Kurahashi, Kayo, Kiselev, Evgeny, Ravji, Azhar, Pommier, Yves, Aihara, Hideki, Wang, Zhengqiang

    “…Tyrosyl-DNA phosphodiesterase 2 (TDP2) repairs topoisomerase II (TOP2) mediated DNA damages and causes resistance to TOP2-targeted cancer therapy. Inhibiting…”
    Get full text
    Journal Article